A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to help answer if LY2127399 is safe and effective in the
treatment of rheumatoid arthritis while on a background treatment of methotrexate.
This study is comprised of 3 periods:
Period 1: 52-week blinded treatment
Period 2: additional 48-week unblinded treatment
Period 3: 48-week post-treatment follow-up